Prenatal Exposure to Gabapentin Alters the Development of Ventral Midbrain Dopaminergic Neurons

Background: Gabapentin is widely prescribed as an off-label drug for the treatment of various diseases, including drug and alcohol addiction. Approximately 83–95% of the usage of gabapentin is off-label, accounting for more than 90% of its sales in the market, which indicates an alarming situation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsanie, Walaa F., Abdelrahman, Sherin, Alhomrani, Majid, Gaber, Ahmed, Habeeballah, Hamza, Alkhatabi, Heba A., Felimban, Raed I., Hauser, Charlotte A. E., Tayeb, Hossam H., Alamri, Abdulhakeem S., Raafat, Bassem M., Anwar, Sirajudheen, Alswat, Khaled A., Althobaiti, Yusuf S., Asiri, Yousif A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356305/
https://www.ncbi.nlm.nih.gov/pubmed/35942222
http://dx.doi.org/10.3389/fphar.2022.923113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356305/
https://www.ncbi.nlm.nih.gov/pubmed/35942222
http://dx.doi.org/10.3389/fphar.2022.923113

Ejemplares similares